Françoise Schmitt1, Elise Riquin2, Marion Beaumesnil3, Mickaël Dinomais4, Philippe Topart5, Dominique Weil6, Jean Malka7, Régis Coutant8, Guillaume Podevin9, Natacha Bouhours-Nouet10. 1. Pediatric Surgery Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: FrSchmitt@chu-angers.fr. 2. Pediatric Psychiatry Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: Elise.Riquin@chu-angers.fr. 3. Centre de Rééducation des Capucins, 28 Rue des Capucins, B.P. 40329, 49103 Angers Cedex 02, France. Electronic address: marion.beaumesnil@les-capucins-angers.fr. 4. Centre de Rééducation des Capucins, 28 Rue des Capucins, B.P. 40329, 49103 Angers Cedex 02, France. Electronic address: mickael.dinomais@gmail.com. 5. General and Metabolic Surgery Department, Clinique de l'Anjou, 9 Rue de l'Hirondelle, 49000 Angers, France. Electronic address: ptopart@gmail.com. 6. Pediatric Surgery Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: DoWeil@chu-angers.fr. 7. Pediatric Psychiatry Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: JeMalka@chu-angers.fr. 8. Pediatric Endocrinology Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: ReCoutant@chu-angers.fr. 9. Pediatric Surgery Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: GuPodevin@chu-angers.fr. 10. Pediatric Endocrinology Department, University Hospital of Angers, 4, rue Larrey, 49933 Angers Cedex 9, France. Electronic address: NaBouhours-Nouet@chu-angers.fr.
Abstract
BACKGROUND/ PURPOSE: Obesity now affects 3%-4% of the pediatric population and contributes to the increase in cardiac mortality in adulthood. Bariatric surgery is the best treatment for weight loss and the obesity-associated comorbidities in adults. We report here our experience of laparoscopic adjustable gastric banding (LAGB) in adolescents. METHODS: The medical charts of the first 16 patients operated on in our center were reviewed. Data were compiled concerning weight loss, physical and biological comorbidities, health-related quality of life (QOL) and surgical complications before surgery and during 24months of follow-up. RESULTS: The maximal pre-operative median body mass index was 43.0kg·m(-2), decreasing to 33.0kg·m(-2) at 2years post-LAGB, which corresponded to a 49.2% excess body weight loss (p<0.001). Most comorbidities (glucose intolerance, hypertension and sleep apnea) resolved within the first year post-LAGB and QOL was improved on the PedsQL™ scales. No severe surgical complications were noted, with only three re-interventions for device failure (2) or band removal (1). CONCLUSION: LAGB is well tolerated in adolescents and shows a beneficial impact on weight loss and obesity-related comorbidities. Associated with global management, it may have a positive impact on patients' QOL and social and psychological status.
BACKGROUND/ PURPOSE:Obesity now affects 3%-4% of the pediatric population and contributes to the increase in cardiac mortality in adulthood. Bariatric surgery is the best treatment for weight loss and the obesity-associated comorbidities in adults. We report here our experience of laparoscopic adjustable gastric banding (LAGB) in adolescents. METHODS: The medical charts of the first 16 patients operated on in our center were reviewed. Data were compiled concerning weight loss, physical and biological comorbidities, health-related quality of life (QOL) and surgical complications before surgery and during 24months of follow-up. RESULTS: The maximal pre-operative median body mass index was 43.0kg·m(-2), decreasing to 33.0kg·m(-2) at 2years post-LAGB, which corresponded to a 49.2% excess body weight loss (p<0.001). Most comorbidities (glucose intolerance, hypertension and sleep apnea) resolved within the first year post-LAGB and QOL was improved on the PedsQL™ scales. No severe surgical complications were noted, with only three re-interventions for device failure (2) or band removal (1). CONCLUSION: LAGB is well tolerated in adolescents and shows a beneficial impact on weight loss and obesity-related comorbidities. Associated with global management, it may have a positive impact on patients' QOL and social and psychological status.
Authors: Meg H Zeller; Emma C Pendery; Jennifer Reiter-Purtill; Sanita L Hunsaker; Todd M Jenkins; Michael A Helmrath; Thomas H Inge Journal: Surg Obes Relat Dis Date: 2017-03-22 Impact factor: 4.734
Authors: Lindel C Dewberry; Anahita Jalivand; Resmi Gupta; Todd M Jenkins; Andrew Beamish; Thomas H Inge; Anita Courcoulas; Michael Helmrath; Mary L Brandt; Carroll M Harmon; Mike Chen; John B Dixon; Margaret Zeller; Marc P Michalsky Journal: Obes Surg Date: 2020-06 Impact factor: 4.129
Authors: Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman Journal: Surg Obes Relat Dis Date: 2018-03-23 Impact factor: 4.734
Authors: Lauren A Sarno; Steven E Lipshultz; Carroll Harmon; Nestor F De La Cruz-Munoz; Preetha L Balakrishnan Journal: Pediatr Res Date: 2019-08-11 Impact factor: 3.756